Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Algernon Pharmaceuticals Inc.
C.AGN
Alternate Symbol(s):
AGNPF
Consumer Cyclical
Healthcare
Advertising Agencies
Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N...
-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:AGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
(1122)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jun 18, 2021 2:14am
RE:RE:RE:RE:The IPF and Chronic Cough study is now on the back burner.
Pulled this off the website but I do not see any follow up. Anybody have any input? This looks like the only thing that may give some life in 2021 December 24, 2020 11:42 ET | Source
...more
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Comment by
BlaineBorg
on Jun 18, 2021 1:41am
RE:RE:RE:The IPF and Chronic Cough study is now on the back burner.
Oh...but for the COVID-19 story dragging itself out from one quarter to the next, what would be the story at Algernon Pharmaceuticals since the launch of the IPF and Chronic Cough study? I'll tell
...more
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m
posted Nov 13, 2024 9:00am by
Freegold Ventures Limited
-
|
Four specific holes were drilled to facilitate additional metallurgical testing and were strategically designed to collect representative material from the deposit while improving infill drilling efforts. Approximately ~2,400 meters of ½ PQ core (~ 20 tonnes) have been shipped to BaseMet Labs in Kamloops, BC, where a comprehensive suite of metallurgical testing is currently underway ...read more
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Comment by
BlaineBorg
on Jun 18, 2021 1:33am
RE:RE:The IPF and Chronic Cough study is now on the back burner.
Those are just random numbers. They don';t apply to any and all clinical trials. You need only review the Topline data news release. It shows a phase 3 for Ifenprodil could range anywhere from 450
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Jun 18, 2021 12:38am
RE:The IPF and Chronic Cough study is now on the back burner.
Yes it is unfortunate the time a bio company takes to get through the process of phase 1-2-3 and it's not tree. Phase 1 - 1.5 mil and 6 months to have a drug made Phase 2 - 3-6 mil and 6-9 month
...more
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Post by
BlaineBorg
on Jun 17, 2021 11:39pm
The IPF and Chronic Cough study is now on the back burner.
SH: Moving into the rest of the year, what milestones should investors be keeping an eye out for? CJM: I think milestone one is feedback from the FDA on our COVID story. Let's see what next
...more
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Post by
BlaineBorg
on Jun 17, 2021 1:25pm
1 can only hope 1 day there'll b news d market truly values.
Do we still have a meeting scheduled with the FDA for COVID-19? That was like 7 news releases ago. BB
(79)
•••
Danorrn
X
View Profile
View Bullboard History
Comment by
Danorrn
on Jun 17, 2021 1:22pm
RE:My final Algernon comments....
I agree with you. Unfortunately, I had faith here and should've bailed at .35 but I didn't. Now the summer doldrums are around the corner and this company will have to do another raise to fund
...more
(2)
•••
MoneyTalks22
X
View Profile
View Bullboard History
Post by
MoneyTalks22
on Jun 17, 2021 9:17am
First Human Study - DMT Stroke Program
Algernon Pharmaceuticals Targets First Human Study of its Psychedelic Drug DMT Stroke Program for Q4, 2021 C.AGN | 2 hours ago VANCOUVER, British Columbia, June 17, 2021 (GLOBE NEWSWIRE) -
...more
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Comment by
BlaineBorg
on Jun 17, 2021 3:42am
RE:RE:RE:RE:"We've got lots on the go and just encourage investors to...
A drug can be FDA approved for sale with a patent pending. It's not a new concept but more like Business 101.. As you said .. I'm not wrong. It's Either - Or. Yes or No It can't be
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Jun 17, 2021 12:09am
RE:RE:RE:"We've got lots on the go and just encourage investors to...
You're not wrong , but you're not right as they still don't have a patent. On the Data side though, if the 20 patients haven't been treated yet, something has occurred that they aren
...more
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Comment by
BlaineBorg
on Jun 16, 2021 7:56pm
RE:RE:"We've got lots on the go and just encourage investors to...
Whether your trading philosophy is accurate or not it doesn't address the bigger issue. Algernon is a data driven stock. Without data there is no company. They can run PP's til their blue in
...more
(5)
•••
TheBearInTheWoods
X
View Profile
View Bullboard History
Comment by
TheBearInTheWoods
on Jun 16, 2021 5:44pm
RE:"We've got lots on the go and just encourage investors to...
Situations like AGN last year are a great learning opportunity to how the market really acts especially on the CSE. When you pivot your company to what is the Flavour of the market and then you pay
...more
(17)
•••
BlaineBorg
X
View Profile
View Bullboard History
Post by
BlaineBorg
on Jun 15, 2021 8:49pm
"We've got lots on the go and just encourage investors to...
continue to be supportive if they like the story and if they like the progress and I mean that's a personal decision." - CEO of Algernon Pharmaceuticals - Facebook Live on April 5, 2021
...more
(1)
•••
Unclebuckshot
X
View Profile
View Bullboard History
Comment by
Unclebuckshot
on Jun 15, 2021 6:55pm
RE:My final Algernon comments....
Thank you for your opinion over the last year. good look in your future endeavours
(9)
•••
talisman47
X
View Profile
View Bullboard History
Post by
talisman47
on Jun 15, 2021 4:38pm
My final Algernon comments....
Algernon is a penny stock "pharmaceutical company " onthe VSE that to get noticed would need to be on Nasdaq "if" they ever get some great news. They look to existing drugs for
...more
Prev
...
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Meet the Top 5 Best Online Brokerages in Canada
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.
Geodrill Generates Revenue of $34.1M, a 13% Increase Compared to $30.3M for Q3-2023
Gold, growth and sustainability in focus for this resource company
Star Diamond Corporation Announces Third Quarter 2024 Results
Coppernico Drills 19 Meters of 0.50% Copper in First 5 Holes and Applies for Additional Permits
Explained: The Psychology of Options Trading with Practical Tips